Special notice: For important updates about COVID-19 and its impact on CNSI facilities, please visit our Coronavirus guidance page.
Research priorities of the CNSI at UCLA build upon the work of our Members, over 150 leading faculty representing nearly 35 Departments. CNSI provides a unique collaborative atmosphere that leverages pooled talent and resources to address the most serious and perplexing questions of our time. The Institute facilitates powerful collaborations among world-class scientists in fields ranging from applied mathematics and engineering to the natural and biomedical sciences. By leveraging the Institute’s central location in the heart of UCLA’s Court of Sciences and proximity to UCLA’s David Geffen School of Medicine, Jonsson Comprehensive Cancer Center, and Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, CNSI supports problem-based, team science initiatives in targeted areas.
Research priorities of the CNSI at UCLA build upon the work of our Members, over 150 leading faculty representing nearly 35 Departments. CNSI provides a unique collaborative atmosphere that leverages pooled talent and resources to address the most serious and perplexing questions of our time. The Institute facilitates powerful collaborations among world-class scientists in fields ranging from applied mathematics and engineering to the natural and biomedical sciences. By leveraging the Institute’s central location in the heart of UCLA’s Court of Sciences and proximity to UCLA’s David Geffen School of Medicine, Jonsson Comprehensive Cancer Center, and Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, CNSI supports problem-based, team science initiatives in targeted areas:
Research Facilitation
The CNSI Grants Facilitation Team works to catalyze interactions between new and existing teams of researchers to develop collaborative proposals that cross disciplines and support the key research mission of the Institute. Our team offers organizational assistance including meeting scheduling, budget construction, editing, and writing assistance to meet submission deadlines with polished proposals in compliance with government, university, and sponsor regulations and requirements.
Research News
April 8, 2021 | CNSI experts examine COVID-19 vaccine efforts
As COVID-19 inoculation efforts continue to ramp up in the U.S. and around the world, two leaders at the California NanoSystems Institute at UCLA recently took stock of the unprecedented success of vaccine design efforts, as well as the challenges ahead. [xyz-ips...
March 30, 2021 | UC group launches clinical trial using CRISPR to correct sickle cell disease gene defect
Scientists at UCLA, UC San Francisco and UC Berkeley have received U.S. Food and Drug Administration approval to jointly launch an early phase, first-in-human clinical trial of a CRISPR gene correction therapy in patients with sickle cell disease using the patients’...
March 30, 2021 | Merck KGaA’s ATR Inhibitor Shows Promise in Both Cancer and COVID-19
A research collaboration among UCLA investigators and Merck KGaA, has pointed to the drug as showing promise for COVID-19. It is also being touted for its unusually broad effect in treating a range of cancers. Merck KGaA's ATR Inhibitor...
March 26, 2021 | ONO Joins the University of California Drug Discovery Consortium
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President, Representative Director, Gyo Sagara; “ONO”) announced that it has joined the University of California Drug Discovery Consortium (Irvine, CA, U.S.; “UC DDC”). ONO Joins the University...
March 26, 2021 | Object classification through a single-pixel detector
UCLA researchers have reported a new, single-pixel machine vision framework that provides a solution to mitigate the shortcomings and inefficiencies of traditional machine vision systems. Object classification through a single-pixel...
March 24, 2021 | 3D fluorescence microscopy gets a boost using recurrent neural networks
By devising a new recurrent neural network, UCLA researchers have demonstrated a deep learning-enabled volumetric microscopy framework for 3D imaging of fluorescent samples. 3D fluorescence microscopy gets a boost using recurrent neural...
March 24, 2021 | Potential COVID-19 treatment identified in UCLA-led lab study
A collaboration among scientists from UCLA and other universities in California, Delaware and Germany, as well as a German pharmaceutical company, has singled out a compound that shows promise for treating SARS-CoV-2, the virus that causes COVID-19. In a series of...
March 24, 2021 | UCLA Researchers Develop New, Noninvasive AI Method to Inspect Live Cells and Gain Critical Data
UCLA researchers have developed a new, AI-based algorithm that determines the properties of live biological cells, keeping them intact in the process. UCLA Researchers Develop New, Noninvasive AI Method to Inspect Live Cells and Gain...
March 23, 2021 | Deactivating cancer cell gene boosts immunotherapy for head and neck cancers
By targeting an enzyme that plays a key role in head and neck cancer cells, researchers from the UCLA School of Dentistry were able to significantly slow the growth and spread of tumors in mice and enhance the effectiveness of an immunotherapy to which these types of...
Give to Support a Brighter Future through Nanoscience and Nanotechnology
Your generous support of the California NanoSystems Institute at UCLA will drive innovations that address society’s most urgent challenges and give life to promising ideas for a prosperous future together.